Expanded-spectrum β-Lactamase and Plasmid-mediated Quinolone Resistance
- 1 May 2007
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 13 (5), 803-805
- https://doi.org/10.3201/eid1305.061293
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Prevalence and Genetic Analysis of Plasmid-Mediated Quinolone Resistance Determinants QnrA and QnrS in Enterobacteriaceae Isolates from a French University HospitalAntimicrobial Agents and Chemotherapy, 2006
- The worldwide emergence of plasmid-mediated quinolone resistanceThe Lancet Infectious Diseases, 2006
- Replicon Typing of Plasmids Encoding Resistance to Newer β-LactamsEmerging Infectious Diseases, 2006
- Plasmid-Mediated Quinolone Resistance in AustraliaMicrobial Drug Resistance, 2006
- In Vivo Selection of Fluoroquinolone-Resistant Escherichia coli Isolates Expressing Plasmid-Mediated Quinolone Resistance and Expanded-Spectrum β-LactamaseAntimicrobial Agents and Chemotherapy, 2006
- Emergence of plasmid-mediated resistance to quinolones in EnterobacteriaceaeJournal of Antimicrobial Chemotherapy, 2005
- Association of Plasmid-Mediated Quinolone Resistance with Extended-Spectrum β-Lactamase VEB-1Antimicrobial Agents and Chemotherapy, 2005
- Identification of plasmids by PCR-based replicon typingJournal of Microbiological Methods, 2005
- Molecular Epidemiology of the Integron-Located VEB-1 Extended-Spectrum β-Lactamase in Nosocomial Enterobacterial Isolates in Bangkok, ThailandJournal of Clinical Microbiology, 2001
- Quinolone resistance from a transferable plasmidThe Lancet, 1998